Exagen Inc. Common Stock

XGNNASDAQUSD
3.64 USD
0.21 (5.45%)AT CLOSE (11:59 AM EDT)
3.63
0.01 (0.27%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.63
0.01 (0.27%)
🔴Market: CLOSED
Open?$3.75
High?$3.85
Low?$3.61
Prev. Close?$3.85
Volume?291.3K
Avg. Volume?448.5K
VWAP?$3.73
Rel. Volume?0.65x
Bid / Ask
Bid?$3.39 × 100
Ask?$4.08 × 1.5K
Spread?$0.69
Midpoint?$3.74
Valuation & Ratios
Market Cap?87.9M
Shares Out?24.1M
Float?14.7M
Float %?64.8%
P/E Ratio?N/A
P/B Ratio?6.09
EPS?-$0.83
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Employees
220
Market Cap
87.9M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2019-09-19
Address
1261 LIBERTY WAY
VISTA, CA 92081
Phone: (760) 560-1501
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.47Strong
Quick Ratio?3.47Strong
Cash Ratio?1.71Strong
Debt/Equity?1.79High
ValuationATTRACTIVELY VALUED
Score
92/100
P/E?
N/A
P/B?
6.09FAIR
P/S?
1.29CHEAP
P/FCF?
N/A
EV/EBITDA?
-7.8CHEAP
EV/Sales?
1.35CHEAP
Returns & Efficiency
ROE?
-139.7%WEAK
ROA?
-38.8%WEAK
Cash Flow & Enterprise
FCF?$-14127000
Enterprise Value?$92.2M
Fundamentals ratios updated end of day